Bayer CropScience acquires green, bee health product from Exosect

16th November 2010

Bayer CropScience AG acquires innovative product for the control of varroa mites in honey bees from Exosect Ltd.

Exosect - leading provider of Intelligent Pest Management solutions - has announced the recent acquisition of its unique product for the control of varroa mites in honey bees by Bayer CropScience.

The acquisition was made for an undisclosed figure and gives Bayer CropScience worldwide rights to sell the product* and to further develop a portfolio of bee health products for the control of mites (including varroa mites and tracheal mites) using Exosect’s platform technology, Entostat™*.

 

Martin Brown, Exosect’s Managing Director comments, “After 5 years of research, we are delighted to have developed a product for this incredibly important sector and we believe that Bayer is very well placed to bring the product to market”. Brown continues, “Our platform technology, Entostat powder, has such huge potential in all sectors of pest control that despite our interest in the bee health sector we are unable to give the launch of this product the resource that it deserves. We are now able to use the substantial funds generated from this acquisition to continue to bring further exciting products through from our extensive product development pipeline”. 

This acquisition closely follows a recent round of investment secured by Exosect of over £2.25m and highlights the interest the company is generating in its technology pipeline.

“Bayer is aware of its responsibility as a producer both of crop protection products and of bee health products”, said Dr. Franz-Josef Placke, Head of Development at Bayer CropScience. “Therefore, we are investing in research and development to provide beekeepers with sustainable solutions to improve the health of their bees and beehives.”

 

Background information

*The product, developed by Exosect Ltd., is for the efficient and cost effective control of varroa mites in honey bees. It is based on Entostat powder, Exosects’ patented platform technology and the active ingredient thymol. The Entostat powder, which is derived from a natural ‘food grade’ wax, develops an electrostatic charge, even through very slight movement. When placed in contact with bees, the powder adheres to them and can be passed from one bee to another through direct contact. The technology means that only minute quantities of thymol are required, which reduces the potential for thymol residues in honey crops.

 

 

- Ends -

 

About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.5 billion (2009), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 18,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com

Contact:

Exosect Ltd.

Georgina Donovan, Tel. +44 (0) 23 8060 3959

E-Mail: georgina.donovan@exosect.com

Bayer CropScience AG

Utz Klages, Tel. +49 2173 38-3125

E-mail: utz.klages@bayer.com

 

 
Contact us: Send us an enquiry or call +44(0)845 199 5540
Bayer CropScience acquires green, bee health product from Exosect